Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
USP Pharma is a leading pharmaceutical company in Central and Eastern Europe, specializing in over-the-counter (OTC) medications and consumer healthcare products. Founded in 1992, the company has built a dominant market position in Poland through iconic brands such as Ibuprom, Apap, and Gripex. USP Pharma operates a comprehensive business model that includes research and development, state-of-the-art manufacturing in Wrocław, and an extensive distribution network. The company's portfolio covers a wide range of therapeutic areas, including pain management, respiratory health, digestive wellness, and dietary supplements. With a focus on innovation and accessibility, USP Pharma continues to expand its international footprint while maintaining its status as a trusted provider of healthcare solutions. The company is privately held and remains a key player in the regional pharmaceutical landscape.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on USP Pharma.